Are smokers protected against SARS-CoV-2 infection (COVID-19)? The origins of the myth

被引:0
|
作者
Naomi A. van Westen-Lagerweij
Eline Meijer
Elisabeth G. Meeuwsen
Niels H. Chavannes
Marc C. Willemsen
Esther A. Croes
机构
[1] Trimbos Institute,The Netherlands Expertise Centre for Tobacco Control
[2] Maastricht University,Department of Health Promotion
[3] Leiden University Medical Center,Public Health and Primary Care
关键词
D O I
暂无
中图分类号
学科分类号
摘要
A number of recent studies have found low percentages of smokers among COVID-19 patients, causing scientists to conclude that smokers may be protected against SARS-CoV-2 infection. National and international media were interested in this story and we soon began receiving questions about this topic in general practice. In this article, we shed light on the process that resulted in the misinterpretation of observational research by scientists and the media. We also point out the methodological flaws of various studies on which hasty conclusions were based. Finally, we address the role of primary healthcare providers in mitigating the consequences of erroneous claims about a protective effect of smoking.
引用
收藏
相关论文
共 50 条
  • [21] Candidate drugs against SARS-CoV-2 and COVID-19
    McKee, Dwight L.
    Sternberg, Ariane
    Stange, Ulrike
    Laufer, Stefan
    Naujokat, Cord
    PHARMACOLOGICAL RESEARCH, 2020, 157
  • [22] SARS-CoV-2 infection and COVID-19 vaccination in pregnancy
    Male, Victoria
    NATURE REVIEWS IMMUNOLOGY, 2022, 22 (05) : 277 - 282
  • [23] Eruptive pseudoangiomatosis and SARS-CoV-2 (COVID-19) infection
    Alonzo Caldarelli, Agostina
    Barba, Paula
    Hurtado, Mariana
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (08) : 1028 - 1029
  • [24] Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19)
    Foldes, David
    Hinton, Richard
    Arami, Siamak
    Bain, Barbara J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (07) : 861 - 862
  • [25] Pituitary apoplexy and SARS-CoV-2 (COVID-19) infection
    Ruella, Mauro
    Caffaratti, Guido
    Katz, Debora
    Marengo, Ricardo
    Cervio, Andres
    MEDICINA-BUENOS AIRES, 2023, 83 (01) : 133 - 137
  • [26] The Pathophysiology of COVID-19 and SARS-CoV-2 Infection Reply
    Oning, Dieter B.
    Bloch, Wilhelm
    Kuebler, Wolfgang M.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2021, 321 (03) : L638 - L639
  • [27] SARS-CoV-2 and COVID-19
    Sheng, Wang-Huei
    Ko, Wen-Chien
    Huang, Yhu-Chering
    Hsueh, Po-Ren
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (03) : 363 - 364
  • [28] Authors' response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection
    Harder, Thomas
    Koch, Judith
    Vygen-Bonnet, Sabine
    Kuelper-Schiek, Wiebe
    Pilic, Antonia
    Reda, Sarah
    Scholz, Stefan
    Wichmann, Ole
    EUROSURVEILLANCE, 2021, 26 (35)
  • [29] Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India
    Behera, Priyamadhaba
    Singh, Arvind Kumar
    Subba, Sonu Hangma
    Arjun, Mc
    Sahu, Dinesh Prasad
    Chandanshive, Pradnya Dilip
    Pradhan, Somen Kumar
    Parida, Swayam Pragyan
    Mishra, Abhisek
    Patro, Binod Kumar
    Batmanabane, Gitanjali
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)
  • [30] Homologous and Heterologous Covid-19 Booster Vaccinations Against SARS-CoV-2 Infection in the Elderly
    Acer, Omer
    Bahce, Yasemin Genc
    Ozudogru, Osman
    CURRENT MICROBIOLOGY, 2024, 81 (07)